<DOC>
	<DOC>NCT00918541</DOC>
	<brief_summary>20 patients will be recruited. The aim of the study is to determine the natural progression of atherosclerotic disease.</brief_summary>
	<brief_title>Natural History of Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>stable carotid artery disease not requiring revascularization asymptomatic carotid artery stenosis &lt; 80% or symptomatic patients with stenosis &lt; 60 % prophylactic therapy with aspirin (&gt; 100mg/day, statin, blood pressure therapy if indicated (goal &lt; 130/80 mmHg)) informed consent non atherosclerotic occlusive disease (BÃ¼rgers disease) uncontrolled BP (DBP &gt; 110 mmHg and/or SBP &gt; 200 mmHg) hemorrhagic disease or platelet count &lt; 100'000 mm^3 Known active liver disease (elevations of GPT GOT or increased ammonia) impaired renal function (crea &gt; 180 mmol/l) pregnancy severe claustrophobic reactions short term life threatening pathology physically unable to participate in the study compliance not guaranteed</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>atherosclerotic disease</keyword>
	<keyword>progression</keyword>
	<keyword>natural progression of atherosclerotic disease</keyword>
	<keyword>natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI</keyword>
</DOC>